- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about INZY
Recent news which mentions INZY
12 Health Care Stocks Moving In Thursday's Intraday Session
April 21, 2022
From Benzinga
From Benzinga
30 Stocks Moving In Thursday's Mid-Day Session
April 21, 2022
From Benzinga
From Benzinga
Executives Buy Around $5M Of 3 Penny Stocks
April 21, 2022
From Benzinga
51 Biggest Movers From Thursday
April 18, 2022
From Benzinga
51 Biggest Movers From Yesterday
April 06, 2022
From Benzinga
68 Biggest Movers From Yesterday
April 05, 2022
From Benzinga
35 Stocks Moving In Monday's Mid-Day Session
April 04, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
March 16, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 7, 2022
February 07, 2022
From Benzinga
63 Biggest Movers From Friday
December 20, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 29, 2021
November 29, 2021
From Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
October 28, 2021
From Benzinga
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
October 08, 2021
From Benzinga
The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
October 06, 2021
From Benzinga
The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO
October 01, 2021
From Benzinga
The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug
September 30, 2021
From Benzinga
50 Biggest Movers From Yesterday
September 23, 2021
From Benzinga
The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data
September 21, 2021
From Benzinga
The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs
September 15, 2021
From Benzinga
The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout
September 14, 2021
From Benzinga
The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization
September 09, 2021
From Benzinga
54 Biggest Movers From Yesterday
September 09, 2021
From Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
September 08, 2021
From Benzinga
30 Stocks Moving In Wednesday's Mid-Day Session
September 08, 2021
From Benzinga
62 Biggest Movers From Yesterday
July 28, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.